Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Thermo Fisher Scientific and Innoforce team up on pharma facility in China 

By Brian Buntz | November 6, 2020

Thermo Fisher Scientific Inc. (NYSE:TMO) and Innoforce have agreed to set up a new pharma services facility in Hangzhou, China for biologics and drug development and manufacturing. 

Innoforce is a Hangzhou, China-based contract development and manufacturing company.

The two companies expect to complete the facility in 2022.  

The site will become part of Thermo Fisher’s international pharma services network. The company currently has facilities in 10 companies in the Asia Pacific region, including in China. 

The Hangzhou facility will also comply with relevant regulatory guidelines associated with the China National Medical Products Administration, FDA and  Europe, the Middle East and Africa. 

In related news, Thermo Fisher Scientific recently expanded its direct-to-patient clinical trial service offerings.

“Decentralized clinical trials have been on the rise even before the COVID-19 pandemic due to the location of study centers and the amount of time required for study visits being barriers to patient enrollment and ongoing participation,” said Chris Armstrong, president of the company’s clinical trials business. 

Thermo Fisher is having a banner year so far this year. Its stock has increased in value 62% since the beginning of the year. 

 

Tell Us What You Think! Cancel reply

Related Articles Read More >

coronavirus COVID-19 Pfizer
7 core strategies in Biden’s battle against COVID-19
Biden’s COVID-19 response will make manufacturers busy
Catalent
Catalent to acquire Acorda’s manufacturing and packaging operations 
Halix
Halix to help make AstraZeneca’s COVID-19 vaccine

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards